MCM
IDXX icon

Matarin Capital Management’s Idexx Laboratories IDXX Stock Holding History

Matarin Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,848
Closed -$3.84M – 207
2020
Q1 		$3.84M Buy
+15,848
New +$4.14M 0.6% 78
2018
Q4 		– Sell
-19,120
Closed -$4.77M – 272
2018
Q3 		$4.77M Buy
19,120
+4,220
+28% +$1.02M 0.31% 110
2018
Q2 		$3.25M Sell
14,900
-6,999
-32% -$1.44M 0.23% 138
2018
Q1 		$4.19M Sell
21,899
-4,334
-17% -$800K 0.31% 115
2017
Q4 		$4.1M Buy
26,233
+13
+0% +$2.05K 0.32% 123
2017
Q3 		$4.08M Sell
26,220
-4,750
-15% -$751K 0.35% 118
2017
Q2 		$5M Buy
30,970
+4,750
+18% +$771K 0.46% 88
2017
Q1 		$4.05M Buy
26,220
+10,540
+67% +$1.45M 0.4% 93
2016
Q4 		$1.84M Sell
15,680
-10,345
-40% -$1.18M 0.21% 160
2016
Q3 		$2.93M Buy
+26,025
New +$2.74M 0.32% 127

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Matarin Capital Management's IDXX Position: Q2 2020 in Review

Matarin Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2020, closing a stake of 15,848 shares — an estimated $3.84M sold.

Matarin Capital Management first reported a position in IDXX in Q3 2016 and held it in 10 quarters. The position peaked at $5M in Q2 2017. 802 funds tracked by Wall St. Rank hold IDXX as of Q2 2020.

  • Matarin Capital Management reported no remaining Idexx Laboratories position as of Q2 2020 after selling out during the quarter.
  • Matarin Capital Management sold 15,848 Idexx Laboratories shares in Q2 2020, an estimated $3.84M.
  • Matarin Capital Management first reported a position in Idexx Laboratories in Q3 2016 and held it in 10 quarters.
  • Matarin Capital Management's Idexx Laboratories position peaked at $5M in Q2 2017.
  • 802 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2020.

Based on Matarin Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.